{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:27:04Z","timestamp":1788121624882,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020622","name":"Translational Health Science and Technology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["BT\/NBM099\/02\/18"],"award-info":[{"award-number":["BT\/NBM099\/02\/18"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijbiomac.2022.07.028","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T03:53:44Z","timestamp":1657338824000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design"],"prefix":"10.1016","volume":"217","author":[{"given":"Adarsh Kumar","family":"Chiranjivi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal Ahmad","family":"Parray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubbir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekhar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manidipa","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.V. Venkataram","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supratik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0005","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","article-title":"Dengue viruses and promising envelope protein domain III-based vaccines","volume":"102","author":"Fahimi","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0010","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0015","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006934","article-title":"Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes","volume":"14","author":"Gallichotte","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0025","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1128\/JVI.00606-08","article-title":"Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus","volume":"82","author":"Gromowski","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.str.2017.11.017","article-title":"Structural and functional characterization of a cross-reactive dengue virus neutralizing antibody that recognizes a cryptic epitope","volume":"26","author":"Li","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007836","article-title":"A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III","volume":"15","author":"Hu","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0055","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0060","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1038\/ncomms15411","article-title":"Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope","volume":"8","author":"Rouvinski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A protective zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection","volume":"20","author":"Slon-Campos","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0070","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/JVI.78.5.2367-2381.2004","article-title":"Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses","volume":"78","author":"Keelapang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100641","article-title":"Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein","volume":"9","author":"Hsieh","year":"2014","journal-title":"PLoS One"},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2022.07.028_bb0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1099\/0022-1317-74-2-175","article-title":"Processing of the dengue virus type 2 proteins prM and C-prM","volume":"74","author":"Murray","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0085","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/JVI.73.3.2547-2551.1999","article-title":"PrM- and cell-binding domains of the dengue virus E protein","volume":"73","author":"Wang","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0090","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0095","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1128\/JVI.01180-08","article-title":"Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction","volume":"82","author":"Junjhon","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","article-title":"Enhancing dengue virus maturation using a stable furin over-expressing cell line","volume":"497","author":"Mukherjee","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virusres.2016.12.003","article-title":"Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection","volume":"229","author":"Wang","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122443","article-title":"An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies","volume":"10","author":"Boliar","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12977-016-0312-7","article-title":"Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes","volume":"13","author":"Das","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2017.07.001","article-title":"Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505","volume":"510","author":"Das","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0125","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1099\/jgv.0.001141","article-title":"Characterization of the membrane-bound form of the chimeric, B\/C recombinant HIV-1 Env, LT5.J4b12C","volume":"99","author":"Das","year":"2018","journal-title":"J. Gen .Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0130","doi-asserted-by":"crossref","first-page":"18256","DOI":"10.1073\/pnas.1314351110","article-title":"Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation","volume":"110","author":"Ringe","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0135","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/JVI.76.6.2606-2616.2002","article-title":"Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins","volume":"76","author":"Binley","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0140","doi-asserted-by":"crossref","first-page":"e00745","DOI":"10.1128\/JVI.00745-20","article-title":"Dimerization of dengue virus E-subunits impacts antibody function and domain focus","volume":"94","author":"Thomas","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0145","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/s41598-017-04767-6","article-title":"In vitro assembly and stabilization of dengue and zika virus envelope protein homo-dimers","volume":"7","author":"Metz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0150","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41598-017-01097-5","article-title":"Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells","volume":"7","author":"Slon Campos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0155","doi-asserted-by":"crossref","first-page":"20860","DOI":"10.1074\/jbc.M109.085472","article-title":"Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition","volume":"285","author":"Raska","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0160","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jbiotec.2012.06.038","article-title":"Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells","volume":"161","author":"Croset","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/pr300870t","article-title":"Characterization of host-cell line specific glycosylation profiles of early transmitted\/founder HIV-1 gp120 envelope proteins","volume":"12","author":"Go","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027252","article-title":"Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes","volume":"6","author":"Mattia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0175","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/s41467-019-12677-6","article-title":"Oligomeric state of the ZIKV E protein defines protective immune responses","volume":"10","author":"Metz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0180","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0185","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.celrep.2017.07.077","article-title":"Improving the immunogenicity of native-like HIV-1 envelope trimers by hyperstabilization","volume":"20","author":"Torrents de la Pena","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00264-17","article-title":"Improving the expression and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers by targeted sequence changes","volume":"91","author":"Ringe","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0195","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.celrep.2015.03.047","article-title":"Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design","volume":"11","author":"Sharma","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0200","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3389\/fmicb.2017.01415","article-title":"Dengue virus glycosylation: what do we know?","volume":"8","author":"Yap","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 a resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0210","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/JVI.00116-07","article-title":"Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation","volume":"81","author":"Mondotte","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0215","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1038\/s41598-018-26800-y","article-title":"Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue antibody-dependent enhancement: knowns and unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0230","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/v2122649","article-title":"The complexity of antibody-dependent enhancement of dengue virus infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2019.02.002","article-title":"Structural perspectives of antibody-dependent enhancement of infection of dengue virus","volume":"36","author":"Morrone","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0240","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.mex.2019.04.013","article-title":"Method to identify efficiently cleaved, membrane-bound, functional HIV-1 (Human Immunodeficiency Virus-1) envelopes","volume":"6","author":"Samal","year":"2019","journal-title":"MethodsX"},{"key":"10.1016\/j.ijbiomac.2022.07.028_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J. Struct. Biol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022014520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022014520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T14:55:46Z","timestamp":1737298546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022014520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":49,"alternative-id":["S0141813022014520"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.028","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of soluble, cleaved, well-ordered, native-like dimers of dengue virus 4 envelope protein ectodomain (sE) suitable for vaccine immunogen design","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}